High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Abstract Text:

J Peter van Tintelen,Robert M W Hofstra,Hilga Katerberg,Tom Rossenbacker,Ans C P Wiesfeld,Gideon J du Marchie Sarvaas,Arthur A M Wilde,Irene M van Langen,Eline A Nannenberg,Anneke J van der Kooi,Marian Kraak,Isabelle C van Gelder,Dirk Jan van Veldhuisen,Yvonne Vos,Maarten P van den Berg, ,

BACKGROUND: Among the most frequently encountered mutations in dilated cardiomyopathy (DCM) are those in the lamin A/C (LMNA) gene. Our goal was to analyze the LMNA gene in patients with DCM and/or conduction disease referred to the cardiogenetics outpatient clinic and to evaluate the prevalence of LMNA mutations and their clinical expression. METHODS AND RESULTS: The LMNA gene was screened in 61 index patients. Eleven mutations (including 6 novel) were identified, mainly in the subgroup of familial DCM with cardiac conduction disease (3/10 index patients) and in patients with DCM and Emery-Dreifuss, Limb-Girdle, or unclassified forms of muscular dystrophy (7/8 index patients). In addition, a mutation was identified in 1 of 4 families with only cardiac conduction disease. We did not identify any large deletions or duplications. Genotype-phenotype relationships revealed a high rate of sudden death and cardiac transplants in carriers of the p.N195K mutation. Our study confirmed that the p.R225X mutation leads to cardiac conduction disease with late or no development of DCM, underscoring the importance of this mutation in putative familial "lone conduction disease." Nearly one third of LMNA mutation carriers had experienced a thromboembolic event. CONCLUSIONS: This study highlights the role of LMNA mutations in DCM and related disorders. A severe phenotype in p.N195K mutation carriers and preferential cardiac conduction disease in p.R225X carriers was encountered. Because of the clinical variability, including the development of associated symptoms in time, LMNA screening should be considered in patients with DCM or familial lone conduction disease.

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Publishing Authors By Initials

JP van Tintelen,RM Hofstra,H Katerberg,T Rossenbacker,AC Wiesfeld,GJ du Marchie Sarvaas,AA Wilde,IM van Langen,EA Nannenberg,AJ van der Kooi,M Kraak,IC van Gelder,DJ van Veldhuisen,Y Vos,MP van den Berg, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American heart journal

VOLUME: 154

Page Numbers: 1130-9

Journal Abbreviation: Am. Heart J.

ISSN: 1097-6744

DAY: 14

MONTH: 09

YEAR: 2007

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370465

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

AFFILIATION: Department of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands. p.van.tintelen@medgen.umcg.nl

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am Heart J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics Related Publications

• Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content.
• Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options.
• Collision judgment of objects approaching the head.
• Communication between the corpus cavernosum penis and the corpus spongiosum penis in a bull diagnosed by modified contrast cavernosography: A case report.
• Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation.
• Delayed intrauterine repair of an experimental spina bifida with a collagen biomatrix.
• Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation.
• Energy conversion in microsystems: is there a role for micro/nanofluidics?
• Flash suppression and flash facilitation in binocular rivalry.
• Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device.
• HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.
• High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
• ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.
• Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.
• Lifetime occupation, education, smoking, and risk of ALS.
• Media exposure, mood, and body image dissatisfaction: an experimental test of person versus product priming.
• Multiphase flow in microfluidic systems --control and applications of droplets and interfaces.
• Oral or IV Prednisolone in the Treatment of COPD Exacerbations: A Randomized, Controlled, Double-blind Study.
• Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage.
• Pivotal role of ChIFNgamma in the pathogenesis and immunosuppression of infectious bursal disease.
• RCTs and observational studies to determine the effect of prophylaxis in severe haemophilia.
• Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.
• Redox cycling with facing interdigitated array electrodes as a method for selective detection of redox species.
• Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
• Role of nitric oxide in the inhibition of BMP-2-mediated stimulation of proteoglycan synthesis in articular cartilage.
• Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up.
• Shared risk and protective factors for overweight and disordered eating in adolescents.
• Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints.
• Structural insight into OprD substrate specificity.
• Vascular events after liver transplantation: a long-term follow-up study.